Navigation Links
ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2012 Results
Date:1/5/2012

SAN DIEGO, Jan. 5, 2012 /PRNewswire/ -- RESMED INC. (NYSE: RMD), announced today that on Thursday, January 26, 2012, it will release its results for the second quarter and six months of fiscal year 2012, ended December 31, 2011. A press release with ResMed's results will be issued after 1:00 p.m. Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q2 2012 results webcast". The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be: 

 

9:30 p.m. London 

 

8:30 a.m. Sydney, Australia (January 27, 2012)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:US:617-614-3672Outside US:+1 617-801-9715Conference Name:Q2 2012 ResMed Inc. Results Conference Call  Participant Passcode:92354908The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:US:617-801-6888Outside US:+1 617-801-6888Passcode:23854403ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company
'/>"/>

SOURCE ResMed Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ResMed Inc. Announces Financial Results for the Quarter Ended September 30, 2011
2. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2012 Results
3. ResMed Inc. to Present at Upcoming Conferences
4. CareFusion and ResMed Announce Distribution Agreement for U.S. Hospital Market
5. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
6. ResMed Announces Acquisition of BiancaMed
7. ResMed Announces New iPhone App
8. ResMed Inc. Announces Record Financial Results for the Quarter Ended and Nine Months Ended March 31, 2011
9. The Next Generation in Bilevel Therapy Now Available on ResMeds Award-Winning S9™ Platform
10. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results
11. ResMed Inc. Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... N.C. , Aug. 28, 2015  Delays ... research projects can slow down the decision-making process, ... is, therefore, absolutely critical for biopharmaceutical companies to ... research approval process for quicker and more meaningful ... by Best Practices, LLC, nearly three-quarters of benchmarked ...
(Date:8/28/2015)... Research and Markets ... the "12th Annual Report and Survey of ... their offering. The 2015 12th Annual ... Production is the most recent study of biotherapeutic ... future capacity and production. The report contains the ...
(Date:8/28/2015)... 28, 2015 Research ... of the "Investigation Report on China,s Insulin ... Developed by Novo Nordisk, insulin aspart ... important drug for the treatment of diabetes. Compared ... acting insulin analog, starts working fast and reports ...
Breaking Medicine Technology:Expediting the Pharmaceutical Market Research Process for Faster Insights 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2
... 2011 CeNeRx BioPharma, Inc., a clinical-stage company developing ... nervous system (CNS), today announced FDA approval of its ... for CXB909, a novel agent that has demonstrated utility ... is a small molecule, orally active agent that enhances ...
... 9, 2011 Concentric Medical, Inc. today announced that the ... RE vascularization of large V essel O ... and at Capital Health in Trenton, New Jersey. Oregon Health ... Capital Health was first to use the Trevo device. TREVO ...
Cached Medicine Technology:CeNeRx Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 2CeNeRx Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study 3Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 2Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial 3
(Date:8/29/2015)... ... , ... On Saturday, September 19, 2015, Diane Blackburn-Zambetti, the Director of Policy ... present an educational program titled “Asbestos and Your Health.” , The two and one ... at 6:45pm) at Calvary United Methodist Church, 16 E Park Ave., Ambler, PA 19002. ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , Eau ... shipping costs. , “Before, a threshold of $49.00 was required to qualify for free ... qualify for free standard shipping for customers regardless of the item’s selling price.” , ...
(Date:8/29/2015)... ... 29, 2015 , ... The popular television program VOICES IN AMERICA, hosted by ... will be devoting an entire short segment to the subject of diabetes. Diabetes is ... on a daily basis, but recent advancements in medical science may prove to be ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Day at the Zoo to celebrate children helping children, a thank you to ... throughout West Ohio have contributed to the United Methodist initiative to end malaria ...
(Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Applied Research Foundation to Hold Educational Class About Asbestos and Mesothelioma Prevention 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5
... Rival JoAnne,s Bed & Back; Merger Sets Up Healthy ... Largest Company Owned Back Retail Chain, LORTON, Va., ... focus on home and workplace back wellness created an,ergonomic ... Bed & Back. Healthy Back,s 18 stores and ecommerce ...
... This release is,being sent in a social media format, by ... the NIH., News:, * A new study being ... (Abstract #4020), may change treatment practice,in about 25 percent of ... to the way colorectal cancers will be staged., * ...
... sufferers gain benefit from calcitriol, an oral form , , FRIDAY, ... cut the risk of death for people with moderate to ... study suggests. , During a two-year study of more ... form of activated vitamin D, had their overall risk of ...
... Million for Life-threatening,Disease, BETHESDA, Md., May 16 ... for cystic fibrosis this weekend -- May 17 ... largest national CF,fund-raiser, the Cystic Fibrosis Foundation announced ... Month. Cystic fibrosis is a,life-threatening genetic disease that ...
... who would benefit most from chemo after surgery, study says ... 15 genes may help determine which patients with early-stage non-small ... the most from chemotherapy, a new study shows. , ... with less aggressive forms of the cancer who would be ...
... Millions of Children Still in Danger, NEW YORK, ... The,Advertising Council today announced a partnership to distribute and ... by A-List,celebrities, including Ben Stiller, Nicole Ritchie, Joel Madden, ... help survivors of the,Myanmar cyclone. The Ad Council is ...
Cached Medicine News:Health News:The Back Wars Come to a Close 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3
... 6 is an enzyme immunoassay (EIA) test ... various specific nuclear antigens (SS-A, SS-B, RNP/Sm, ... is used as an aid in the ... connective tissue disease (MCTD), Sjgren's syndrome and ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: